HR 1271 · 115th Congress 2017–2019, ended

DXM Abuse Prevention Act of 2017

Latest action · Mar 17, 2017 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 1, 2017
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

DXM Abuse Prevention Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.

Cosponsors 6

Members who signed on, in the order they did. Signatures ran from Mar 1, 2017 to Jun 5, 2018; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-CADoris O. MatsuiOriginalMar 1, 2017
R-PAPatrick MeehanNov 13, 2017
D-WIRon KindNov 13, 2017
D-FLAlcee L. HastingsDec 1, 2017
D-NYPaul TonkoDec 6, 2017
D-NYYvette D. ClarkeJun 5, 2018

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 1, 2017
Health Subcommittee
Referred Mar 17, 2017

Actions 3

Everything that happened, newest first.

  1. Mar 17, 2017Referred to the Subcommittee on Health.
  2. Mar 1, 2017Introduced in House
  3. Mar 1, 2017Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 1 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 36, March 1, 2017, page H1464.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.
Short Titles as Introduced
DXM Abuse Prevention Act of 2017

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 1, 2017Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.